A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

NCT06320535 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL: R21/Matrix M™ (Group 1)
BIOLOGICAL: R21/Matrix M™ (Group 2)
BIOLOGICAL: R21/Matrix M™ (Group 3)
PROCEDURE: Fine needle aspiration (FNA)

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]